fig4
From: Nanocarrier drug resistant tumor interactions: novel approaches to fight drug resistance in cancer
Figure 4. Tobacco mosaic virus (TMV) delivery of Pt in platinum-resistant ovarian cancer cells (A)[58]; DOX delivery in gH625 Herpes virus derived-protein encapsulated liposome in drug-resistant lung adenocarcinoma cells (B)[59]; Western reverse (WR) vaccinia targeting PGE2 to overcome immunotherapy resistant cancer cells (C)[61]
